WASHINGTON — In a move meant to increase consumer safety and confidence in prescription drugs, the Senate passed a bill this week that would give the U.S. Food and Drug Administration the ability to mandate prescription label changes, pull drugs that are considered dangerous from the market, regulate advertising and order new studies for drugs already on the market. FDA would also maintain a database of drug trials to survey adverse effects. In the past, the agency had to negotiate with ...
REGISTER TO VIEW THIS ARTICLE - Register for a Free Account
Why Register for FREE?
Registering for content on Supermarket News will give you INSTANT access to invaluable articles and media content that industry professionals rely on. You will have access to our special reports, feature articles, and industry analysis. It’s FREE, easy and quick. What are you waiting for! In addition you will also receive complimentary access to the SN salary survey data tables.
Attention Paid Print Subscribers: While you have already been granted free access to SN we ask that you register now. We promise it will only take a few minutes! Or visit your profile and add your print magazine account number and zip code.